NCI-MATCH arms fall short in ASCO abstracts

Three arms of NCI’s Molecular Analysis for Therapy Choice (NCI-MATCH) tissue agnostic basket trial will report overall response rates below 10% at this year’s American Society of Clinical Oncology meeting, according to abstracts released late Wednesday.

NCI-MATCH

Read the full 362 word article

User Sign In